NeuronNeurosciencePeer-reviewed journal article
Interaction of an alpha-synuclein epitope with HLA-DRB1*15:01 triggers enteric features in mice reminiscent of prodromal Parkinson's disease
Francesca GarrettiiD, Connor MonahaniD, Nicholas Sloan, Jamie Bergen, Sanjid ShahriariD, Seon Woo KimiD, Alessandro SetteiD, Tyler Cutforth, Ellen KanteriD, Dritan AgalliuiD, David L. SulzeriD
Abstract
Enteric symptoms, including constipation, are hallmarks of prodromal Parkinsons disease (PD) that can appear decades before the onset of motor symptoms and diagnosis. PD patients possess circulating T cells that recognize specific -synuclein-(-syn)-derived epitopes. One epitope, -syn32-46, binds with strong affinity to the HLA-DRB1*15:01 allele implicated in autoimmune diseases. We report that -syn32-46 immunization in a mouse expressing HLA-DRB1*15:01 triggers intestinal inflammation leading to loss of enteric neurons, damage of enteric dopaminergic neurons, constipation and weight loss. -Syn32-46 immunization activates innate and adaptive immune gene signatures in the gut and induces changes in CD4+ TH1/ TH17 transcriptome that resemble tissue resident memory cells found in mucosal barriers during inflammation. Depletion of CD4+, but not CD8+, T cells partially rescues enteric neurodegeneration. Therefore, interaction of -syn32-46 and HLA-DRB1*15:0 is critical for gut inflammation and CD4+ T cell-mediated loss of enteric neurons in humanized mice, suggesting potential mechanisms of prodromal enteric PD. HIGHLIGHTS AND eTOC BlurbO_LI-syn32-46 immunization of an HLA-DRB1*15:01 mouse triggers weight loss and constipation. C_LIO_LI-syn32-46 immunizations induce gut inflammation, loss of enteric neurons and damage to dopaminergic neurons. C_LIO_LI-syn32-46 immunization induces innate and adaptive immune responses in the gut. C_LIO_LIDepletion of CD4+, but not CD8+, T cells partially rescues enteric neural loss. C_LIO_LIAn interaction between -syn32-46 and HLA-DRB1*15:01 is critical for this model of prodromal PD. C_LI Parkinsons disease (PD) patients exhibit elevated number of circulating T cells that recognize -synuclein-(-syn)- epitopes, particularly during early disease stages. One epitope, -syn32-46, interacts with the HLA-DRB1*15:01; however, its role in PD pathogenesis remains unknown. Garretti et al. show that -syn32-46 immunization of a mouse expressing HLA-DRB1*15:01 triggers intestinal inflammation, a loss of enteric neurons, constipation and weight loss, suggesting a critical role for -syn autoimmunity in HLA-DRB1*15:01 carriers in prodromal PD.
- Citations
- 59
- FWCI
- 9.99
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Experimental colitis drives enteric alpha-synuclein accumulation and Parkinson-like brain pathology
Stefan A. Grathwohl, Quansah, Emmanuel, … Markus Britschgi·Free NeuropathologyPeer-reviewed·Apr 7, 2021
- Alpha Synuclein Induced Immune Response Triggers Parkinson's Disease Like Symptoms
Rebekah G. Parkinson, Tony Xu, … Nathalie Dehorter·bioRxiv·May 27, 2024
- Helicobacter pylori infection and α-synuclein pathology drive parallel neurodegenerative pathways in the substantia nigra
Alejandro Soto-Avellaneda, Alice Prigent, … Michael X. Henderson·Journal of NeuroinflammationPeer-reviewed·Dec 22, 2025
- Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson's disease overexpressing human alpha-synuclein
Mariangela Massaro Cenere, Marta Tiberi, … Nicola Biagio Mercuri·npj Parkinson s DiseasePeer-reviewed·Nov 5, 2024
- α-synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells
Michael J. Hurley, Elisa Menozzi, … Anthony H.V. Schapira·Brain CommunicationsPeer-reviewed·Jan 1, 2023
- Type-I interferons drive the gastrointestinal inflammatory response in a mouse model of Parkinsons disease
Harrison Waters, Shuyan Chen, … Juliet Marie Taylor·Gastro Hep AdvancesPeer-reviewed·Jan 1, 2026